Building a medtech brand?
We run PR and public affairs for companies in this market: from category launches and funding announcements to NHS procurement and regulatory communications.
Handheld neurosurgical robotics
UCL spinout building a handheld robotic platform with wristed instruments as small as 3mm, aiming to bring robotic dexterity to brain and spine surgery without a full robotic tower.
The read
Panda Surgical is developing a handheld robotic system with detachable, wristed instruments as small as 3mm in diameter, intended to give more neurosurgeons access to complex brain and spine procedures without the cost and footprint of a full robotic tower. It was founded in 2022 by CEO Manios Dimitrakakis with UCLH neurosurgeon Hani Marcus and UCL professor Danail Stoyanov.
Its NIHR-backed development programme is working toward the first human trial of handheld robotic technology in brain tumour removal surgery, alongside UCL and UCLH. The company is explicit that its system is pre-market and not yet regulator-approved.
The Bridgehead view
Panda Surgical is an early-stage bet, not a proven vendor, and its own site says as much; it is included here as a live example of the UK's next surgical-robotics generation trying to compete on portability and cost rather than matching Intuitive or CMR feature-for-feature.
FAQs
No. The MedTech Index is independent editorial coverage — we track and write up companies we judge genuinely significant in the sector, and inclusion is not for sale. Where shown, coverage of Panda Surgical above is drawn from public reporting, not sponsored content.
We map the sector by who is actually shaping it: funding, product reach, regulatory engagement and the coverage they earn. The MedTech Index is maintained by our editorial team and updated as the market moves, not compiled from vendor submissions.
Yes. If you represent Panda Surgical, or anything here looks out of date, get in touch through our contact page and we will review it.
Work with us
We run PR and public affairs for companies in this market: from category launches and funding announcements to NHS procurement and regulatory communications.
We advise NHS-facing organisations, providers and health systems on reputation, policy engagement and communications that understand the sector.
Related platforms
Cambridge-built modular soft-tissue surgical robot, Versius, designed to fit into existing operating rooms as a portable alternative to fixed-tower systems.
ReadMerseyside-based surgical training company whose LapAR augmented-reality laparoscopic simulator and Totum CPD platform are used across UK NHS surgical training deaneries.
ReadBuckinghamshire-based, women-owned surgical device manufacturer whose Galaxy II self-retaining retractor and eVeck smoke-evacuation system are listed on NHS Supply Chain and used across NHS and private UK hospitals.
ReadCloud-based AI software generating 3D surgical maps for image-guided endovascular procedures, cleared by both the FDA and in the EU/UK.
Read3D-printed, multi-grip bionic prosthetic arm, the Hero Arm, adopted by the NHS and equivalent European health systems for below-elbow limb differences.
ReadBasingstoke-based manufacturer of advanced prosthetic legs, knees and ankles, in continuous operation since 1890 and still designing and building in the UK.
ReadThe firm that knows medtech
Whether you build medical technology or run the health systems that buy it, we know the market, the media and the regulatory landscape it operates in. Thirty minutes with a partner tells you if we can help.